Effect of growth hormone replacement therapy on plasma brain natriuretic peptide concentration, cardiac morphology and function in adults with growth hormone deficiency

Experimental and Clinical Endocrinology and Diabetes

Volumn 118, Issue 3, 2010, Pages 172-176

  Lazurova I ^a   Pura, M ^c   Wagnerova H ^a   Tajtakova M ^a   Sedlakova M ^a   Toma L ^a   Payer, J ^b   Hruzikova P ^b   Vauga, P ^c   Podoba, J ^d   Trejbalova L ^e   Popovic, V ^f   Koltowska Haggstrom M ^g,h  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c National Institute of Endocrinology and Diabetology   (Slovakia)

^d School of Public Health   (Slovakia)

^e Derer 's University Hospital Slovakia   (Slovakia)

^f University Clinical Center   (Serbia)

^g PFIZER INC   (United States)

^h UPPSALA UNIVERSITY   (Sweden)

Author keywords

Brain natriuretic peptide (BNP); Deceleration time; Echocardiography; Growth hormone deficiency; Growth hormone replacement

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; CONTROLLED STUDY; DECELERATION; ECHOCARDIOGRAPHY; FEMALE; GROWTH HORMONE DEFICIENCY; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PRIORITY JOURNAL; SEX DIFFERENCE; TIME;

ADULT; HEART VENTRICLES; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; STROKE VOLUME; YOUNG ADULT;

EID: 77949505037     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0029-1220688     Document Type: Article

References (25)

1. Abs R, Rasmusen UF, Mattsson AF et al. Determinants of cardiovascular risk in 2589 hypopituitary growth hormone deficient adults a KIMS database analysis. Eur J Endocrinol 2006 155 79-90
2. Amato G, Mazziotti G, Di Somma C et al. Recombinant growth hormone therapy in growth hormone deficient adults: A long-Term Controlled Study on Daily Versus Thrice Weekly Injection. J Clin Endocrinol Metab 2000 85 3720-3725
3. Andreassen M, Faber J, Vestergaard H et al. N-terminal pro-B-type natriuretic peptide in patients with growth hormone disturbances. Clin Endocrinol 2007 66 619-625
4. Attanasio AF, Lamberts SW, Matranga AMC et al. Adult growth hormone (GH) deficient patients demonstrate heterogeneity between Childhood onset and Adult onset before and During Human growth hormone treatment. Adult growth hormone deficiency study group. J Clin Endocrinol Metab 1997 82 82-88
5. Baum HBA, Katznelson L, Sherman JC et al. Effects of physiological growth hormone therapy on condition and quality of life in patients with adult onset GH deficiency. J Clin Endocrinol Metab 1998 83 3184-3189
6. Begtsson BA, Johansson G, Shalet SM et al. Treatment of growth hormone deficiency in adults. J Clin Endocrinol Metab 2000 85 933-942
7. Burger AG, Monson JP, Colao AM et al. Cardiovascular risk in patients with growth hormone deficiency effects of growth hormone substitution. Endocr Prac 2006 12 682-689
8. Ceyhun C, Unal S, Yenisey C et al. The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction:correlation with echocardiographic indexes in hypertensive patients. Int J Card Imaging 2007 24 253-259
9. Cho G, Jeong I, Kim S et al. Effect of growth hormone on cardiac contractility in patients with adult onset growth hormone deficiency. Am J Cardiol 2007 100 1035-1039
10. Colao A, Di Somma C, Cuoccolo A et al. Improved cardiovascular risk factors and cardiac performance after 12 months of GH replacement in young adult patients with growth hormone deficiency. J Clin Endocrinol Metab 2001 86 1874-1881
11. Colao A, Vilale G, PivonelloR et al. The heart: an end-organ of growth hormone action. Eur J Endocrinol 2004 151 (Suppl 1) 93-101
12. Colao A, Di Somma C, Cuoccolo A et al. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology and performance and atherosclerosis? Results of a two-years open, prospective study in young adult men and women with severe GH deficiency. J Clin Endocrinol Metab 2005 90 5146-5155
13. Colao A, Di Somma C, Rota F et al. Short term effects of growth hormone treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency. J Clin Endocrinol Metab 2005 90 2056-2062
14. Fischer M, Baessler A, Hense HW et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic based survey of a population sample. Eur Heart J 2003 24 320-325
15. Follin C, Thiln U, Ahrn B et al. Improvement in cardiac systole function and reduced prevalence of metabolic syndrome after two years of growth hormone treatment in growth hormone deficient adult survivors of childhhod-onset acute lymphoblastic leukemia. J Clin Endocrinol Metab 2006 91 1872-1875
16. Gotherstrom G, Bengtsson BA, Bosaeus I et al. A 10-year, prospective study of the metabolic effects of growth hormone replacement in dults. J Clin Endocrinol Metab 2007 92 1442-1445
17. Gutirrez LP, Koltowska-Häggström M, Mattson AF et al. Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database). Pharmacoepidemiol Drug Saf 2008 17 90-102
18. Johansson G, Sverrisdotir YB, Ellegard L et al. Growth hormone increases extracellular volume by stimulating Sodium reabsorption in the distal nephron and preventing pressure natriuresis. J Clin Endocrinol Metab 2002 87 1743-1749
19. Lanes R, Gunczler P, Lopez E et al. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone deficient adolescents. J Clin Endocrinol Metab 2001 86 1061-1065
20. Longobardi S, Cuocolo A, Merola B et al. Left ventricular function in young adults with childhood and adult onset growth hormone deficiency. Clin Endocrinol 1998 48 137-143
21. Merola B, Cittadini A, Colao A et al. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab 1993 77 1658-1661
22. Minczykowski A, Gryczynska M, Ziemnicka K et al. The influence of growth hormone therapy on ultrasound myocardial tissue characterisation in patients with childhood onset growth hormone deficiency. Int J Cardiol 2005 101 257-263
23. Nakao S, Goda A, Yuba M et al. Characterization of left ventricular filling abnormalities and its relation to elevated plasma BNP level in acute to chronic diastolic heart failure. Circ J 2007 71 1412-1417
24. Valcavi R, Gaddi O, Zini M et al. Cardiac preformance and mass in adults with hypopituitarism: effects of one year of GH treatment. J Clin Endocrinol Metab 1995 80 659-666
25. Wallaschofski H, Saller B, Spilcke-Liss E et al. Effects of growth hormone treatment on B type natriuretic peptide as a marker of heart failure in adults with growth hormone deficiency. Horm Metab Res 2006 38 656-661